Embecta Corp. Common Stock (EMBC) is a publicly traded Healthcare sector company. As of July 23, 2026, EMBC trades at $3.26 with a market cap of $192.81M and a P/E ratio of 1.96. EMBC moved +0.31% today. Year to date, EMBC is -72.64%; over the trailing twelve months it is -72.06%. Its 52-week range spans $2.77 to $21.48. Analyst consensus is sell with an average price target of $4.00. Rallies surfaces EMBC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for EMBC, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $3.26 |
| Market Cap | $192.81M |
| P/E Ratio | 1.96 |
| EPS | $1.64 |
| Dividend Yield | 0.01% |
| 52-Week High | $21.48 |
| 52-Week Low | $2.77 |
| Volume | 997.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.08B |
| Net Income | $95.40M |
| Gross Margin | 62.64% |
3 analysts cover EMBC: 0 strong buy, 0 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $4.00.